Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.

[1] The company was founded in 1976 by Roger C. Lucas as Research and Diagnostic Systems, Inc.

[1] In March 2013, Charles (Chuck) Kummeth was named chief executive officer of the company.

[12][13][14] In June 2015, the company agreed to acquire Cliniqa Corporation.

[33] In June 2022, the business announced it would acquire Namocell Inc.[34] In June 2023, Bio-Techne announced it would acquire Lunaphore Technologies SA,[35] the transaction was completed the following month[36]